Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...

Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers.

The treatment reprograms T cells to hunt down a patient's cancer. The approach could speed treatment and cut costs, but needs more study. With just a single injection, a new treatment transforms ...